We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report Mexico - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Mexico - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Mexico: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Mexico

The Mexican prophylactic medicaments containing insulin market declined to $X in 2022, reducing by -2.2% against the previous year. The market value increased at an average annual rate of +3.2% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Over the period under review, the market reached the peak level at $X in 2017; however, from 2018 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Mexico

In value terms, prophylactic medicaments containing insulin production declined to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +3.1% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 with an increase of 11% against the previous year. Prophylactic medicaments containing insulin production peaked at $X in 2017; however, from 2018 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Mexico

Prophylactic medicaments containing insulin exports from Mexico amounted to X tons in 2019, almost unchanged from the previous year's figure. Over the period under review, exports faced a precipitous setback. The smallest decline of -7.3% was in 2014. Over the period under review, the exports hit record highs at X tons in 2012; however, from 2013 to 2019, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports totaled $X in 2019. Overall, exports recorded a precipitous curtailment. The smallest decline of -17.2% was in 2014. The exports peaked at $X in 2012; however, from 2013 to 2019, the exports remained at a lower figure.

Exports by Country

Guatemala (X tons) was the main destination for prophylactic medicaments containing insulin exports from Mexico, accounting for a approx. 100% share of total exports.

From 2012 to 2019, the average annual growth rate of volume to Guatemala amounted to -9.3%.

From 2012 to 2019, the average annual growth rate of value to Guatemala totaled +13.5%.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2019, remaining relatively unchanged against the previous year. Over the period under review, the export price showed prominent growth. The most prominent rate of growth was recorded in 2015 when the average export price increased by 21% against the previous year. Over the period under review, the average export prices attained the maximum in 2019 and is expected to retain growth in years to come.

As there is only one major export destination, the average price level is determined by prices for Guatemala.

From 2012 to 2019, the rate of growth in terms of prices for Guatemala amounted to +25.1% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Mexico

In 2022, prophylactic medicaments containing insulin imports into Mexico fell markedly to X tons, which is down by -87.5% against 2021. Over the period under review, imports continue to indicate a precipitous decline. The most prominent rate of growth was recorded in 2020 with an increase of 63%. Imports peaked at X tons in 2015; however, from 2016 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports reduced markedly to $X in 2022. Overall, imports saw a sharp contraction. The pace of growth appeared the most rapid in 2020 when imports increased by 60%. Over the period under review, imports attained the maximum at $X in 2015; however, from 2016 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Germany (X tons) was the main prophylactic medicaments containing insulin supplier to Mexico, with a approx. 100% share of total imports.

From 2012 to 2022, the average annual growth rate of volume from Germany amounted to -22.6%.

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Mexico.

From 2012 to 2022, the average annual growth rate of value from Germany totaled -25.9%.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, which is down by -6% against the previous year. Overall, the import price recorded a mild downturn. The pace of growth was the most pronounced in 2018 an increase of 39%. Over the period under review, average import prices attained the peak figure at $X per ton in 2015; however, from 2016 to 2022, import prices remained at a lower figure.

As there is only one major supplying country, the average price level is determined by prices for Germany.

From 2012 to 2022, the rate of growth in terms of prices for Denmark amounted to +14.5% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of in 2021 were China, the United States and India, together accounting for 52% of global consumption.
The countries with the highest volumes of in 2021 were China, the United States and India, together comprising 52% of global production.
In value terms, Germany constituted the largest supplier of prophylactic medicaments containing insulin to Mexico.
In value terms, the largest markets for prophylactic medicaments containing insulin exported from Mexico were El Salvador, Venezuela and Nicaragua, together accounting for 60% of total exports.
In 2021, the average prophylactic medicaments containing insulin export price amounted to $56,337 per ton, dropping by -1.9% against the previous year.
In 2021, the average prophylactic medicaments containing insulin import price amounted to $542,607 per ton, increasing by 130% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Mexico. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

  • Mexico

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Mexico
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE

  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023

  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 279

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.

U.S. - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 296

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..

China - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 264

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.

EU - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 305

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.

World - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 357

This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.

Free Data: Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Mexico
Table
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Mexico - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Mexico - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Mexico - Report